Tony Y. Hu Research Group

Tulane University

A useful disease signal may be present in blood but too faint for a conventional assay to detect. Tony Hu develops nanomaterial platforms and proteomic approaches that improve biomarker capture or amplify signals from pathogens and extracellular vesicles. His research aims to improve diagnostic sensitivity, specificity, and quantitative measurement in complex biological samples, with applications including tuberculosis and viral identification. The work connects nanotechnology, biomarker discovery, and clinical diagnostic needs, offering a focused research match for interests in analytical tools and personalized diagnosis.